London, McPeak Receive NIH Award to Study HIV Prevention

The National Institutes of Health has awarded $74,211 to a project that includes Professor Andrew London (Sociology) and Professor John McPeak (Public Administration and International Affairs) to learn more about how best to motivate young at risk men to take medicine to prevent HIV. 

London and McPeak have teamed up with researchers from SUNY Upstate Medical University (Dr. Elizabeth Asiago-Reddy) and the University of Rochester (Dr. Theresa Senn) for the one-year study sponsored by the University of Rochester Center for AIDS Research. The team will conduct in-depth interviews with young gay men in Syracuse and Rochester and create a unique type of survey, called a Discrete Choice Experiment, to determine how young gay men prioritize PrEP options. PrEP (Pre-exposure prophylaxis) is a daily pill which is highly effective at preventing HIV.  While the numbers of people taking PrEP have steadily increased in the last year, the U.S. group at highest risk for HIV--young gay men, and particularly young gay men of color--are often not on PrEP. 

The team's combined expertise in public policy, sociology, economics, clinical medicine, and psychology will allow for a unique and fresh approach to this important component of current efforts to end the HIV epidemic.